Pharmaceutical giant Eli Lilly, one of the country's leading insulin makers, announced Wednesday that it will slash its high list prices for some of its insulins and will immediately offer programs to limit out-of-pocket costs to $35 per month for people with commercial insurance as well as those who are uninsured.
#people #years #immediately #federal-government #governments #million-americans #insurance-companies #beneficiaries
[
add
]
[
|
|
...
]